A closer look at “US Military Races to Develop Synthetic Blood for Battlefield Trauma”, exactly as the source publishes it. In February 2007, a CH-47 Chinook helicopter with call sign Morphine 1-2 evacuated wounded soldiers to Balad Air Base, Iraq, highlighting the urgent need for blood in combat zones. The mission, through insurgent-held territory in daylight, underscored the logistical challenges of supplying real blood to remote battlefields. Now, the US military is investing heavily in developing synthetic blood substitutes to save lives when donor blood is unavailable.
Key players include the Defense Advanced Research Projects Agency (DARPA) and biotech firms like KaloCyte, which is testing ErythroMer, a dried, bio-artificial red blood cell product. The military's interest stems from the high rate of hemorrhage deaths among combat casualties and the difficulty of cold-chain storage in austere environments. This listing links straight to the original page, where the content is available in full.